The mental-health-focused biopharma Atai Life Sciences N.V. (Nasdaq:ATAI) has named Stephen Bardin to be its chief financial officer (CFO) in the third quarter of 2022.  “Atai’s mission to transform mental health is deeply personal and meaningful for me — as it is for so many,” Bardin shared in a LinkedIn post.  Most recently, Bardin was…